C&EN Whitepaper
Addressing The Evolving Challenge of Analyzing N-Nitrosamines in Pharmaceuticals
Brought to you by Sannova Analytical Inc.

This whitepaper discusses the challenges of analyzing pharmaceuticals for trace levels of nitrosamines, both known and unknown. Adding to the challenge is the fact that U.S. and European regulators have taken different approaches to regulating nitrosamine contamination.

Key Objectives:
  • What are nitrosamines/chemical understanding
  • Method of analysis (by GC-MS, LC-MS, and most recently HRMS)
  • Nitrosamines in drug products, APIs, excipients etc. is an evolving research area
  • Sannova, with high-end instrumentation and expertise, has the capability to nimbly adapt to both regulator’s and client’s needs in this matter.

Brought to you by:
Please complete the form to download the white paper.
By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) via email, in accordance with the ACS Privacy Policy .

Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy